Ali Mourad

Assessing the prognostic value of KRAS mutation combined with tumor size in stage I-II non-small cell lung cancer: a retrospective analysis

V. Sayin, Sama I. Sayin, Henrik Fagman, 2024, Frontiers in Oncology.